NTPC plans to award 13.6 GW of thermal capacity by FY27

State-owned power company NTPC Ltd plans to award an additional 13.6 gigawatt (GW) of thermal capacity by the financial year 2026-27 in line with the government’s target of adding more thermal based capacities to meet the rising power demand. The company intends to commission 2.7 GW of thermal capacity by the end of the current financial year and another 1.46 GW in FY26, the company’s Director (Finance) Jaikumar Srinivasan said on Friday.

“We are actively considering awarding thermal capacity to the tune of 13.6 GW by FY27. This is in addition to 11.16 GW thermal capacity already under construction. Furthermore, to have greater fuel security, we are enhancing our coal mining capacity as well,” Srinivasan said on an analyst call. “We plan to enhance estimated NTPC Group’s coal production from 40 million metric tonnes in FY25 to about 67 million metric tonnes up to FY29.”

In the renewable energy segment, the company, through its wholly owned subsidiary NTPC Green Energy Ltd, aims to add 3 GW of green capacity by the end of current financial year with plans to add another 5 GW by FY26, and 8 GW by FY27. The company presently has an operational renewable energy capacity of close to 4.3 GW. 

“Going beyond that, it has to be a progressive plan. We will be simultaneously entering into the bidding process. We are thoroughly procuring it and also seeking land connectivity on a parallel side,” the company said.

NTPC is expected to come out with its initial public offering (IPO) for NGEL in the third quarter of FY25. The management noted that there is no valuation that has been decided for the subsidiary right now. “We are still in the process, and we are hopeful that we will conclude it by Q3FY25,” Srinivasan said.

He added that going forward NGEL will have an edge and access to a lot of multilateral loans from financial institutions exclusively focusing on green energy, renewable energy and ESG.

NTPC on Thursday reported an increase of 14% in its consolidated net profit for the second quarter of the financial year 2024-25 at Rs 5,380.25 crore from Rs 4,726.40 crore in Q2FY25. On a sequential basis, however, the net profit declined by a marginal 2.3%.

The company’s revenue from operations for the quarter under review stood at Rs 44,696.30 crore,

 » Read More

Related Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Trump tariff impact: Pharma stocks surge over 4% on tariff exemption

It’s a party for pharma stocks on Dalal Street. The Nifty Pharma Index is up nearly 4% and Sun Pharma, Gland Pharma and IPCA Labs see gains close to 4% each. Even Lupin and Natco Pharma are rallying smartly. In a major relief, Indian pharmaceutical companies breathed a sigh of relief after US President Donald

Trump tariff impact: Tech stocks plummet, Nifty IT cracks 2.5%

The share price of IT stocks slumped after US President Donald Trump’s administration imposed 26% reciprocal tariffs on Indian imports to the US. The Nifty IT, a basket of Indian tech stocks, fell 2.5% to 35,371.55 levels.  All the constituents of the sectoral index were trading in the red. The share price of Persistent Systems

Trump tariffs send shockwaves across global markets; US futures crash, gold soars to new highs- 10 cues you need to track now

Indian stock markets are set for a turbulent start as global jitters over Trump’s new tariffs weigh on. Early trends from GIFT Nifty point to a sharp drop of over 350 points, signaling a weak opening for Sensex and Nifty 50. Indian stock markets ended on a positive note in the previous trading session, with

‘Pramerica Life targets Rs 3,000-crore GWP in FY26,’ Pankaj Gupta

Pramerica Life Insurance, a joint venture between subsidiaries of Piramal Capital and Housing Finance and US-based Prudential Financial Inc, aims to close FY26 with Rs 3,000 crore in gross written premium. In an interview with Narayanan V, managing director and CEO Pankaj Gupta discusses the products and distribution strategy. Excerpts: Life insurance premiums have been

Tata small cap fund: Targeting growth at reasonable valuations

Tata Small Cap Fund is a growth-oriented scheme in the Small Cap Fund category that has exhibited a noteworthy track record since its inception and has outpaced many of its prominent peers, thereby rewarding investors with superior risk-adjusted returns. Launched in November 2018, Tata Small Cap Fund aims to invest in stocks of companies that are in growth